dallas semaglutide side effect lawsuit A surprising known as “ghost fat” is being reported by some users of injectable weight-loss drugs. Read what experts say is behind the phenomenon. https://www.8newsnow.com/news/national-news/ghost-fat-is-a-surprising-side- effect-of Ozempic Lawsuit – July 2026

The most recent developments regarding therapies based on incretin hormones (glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)) are likely to fundamentally change our therapy for type 2 diabetes mellitus (T2DM), obesity and conditions associated with diabetes and obesity, i

Its mechanism involves mimicking the GLP-1 hormone produced by your body

As the cost of GLP-1s comes down, I think there will be even more awareness and ability for general practitioners and clinicians to use them in their daily practices, Dr

As summarized in the award announcement, Bjerre Knudsen and DiMarchi overcame significant obstacles in bringing these drugs to patients seeking to lose weight

That change is easy to miss in the marketing materials but it meaningfully affects the monthly cost

The argument can be made, as Virta Health does (see image below), that overall heart disease risk decreases significantly, at least in patients with type 2 diabetes, even as LDL cholesterol might increase